FDA green lights Ofev to treat idiopathic pulmonary fibrosis

October 16, 2014 4:40 PM

3 0

FDA green lights Ofev to treat idiopathic pulmonary fibrosis

The FDA has approved a new drug, Ofev, for treating patients with idiopathic pulmonary fibrosis.

Pulmonary fibrosis is serious a disease that involves the thickening and stiffening of the tissue deep in the lungs over time. The formation of scar tissue is called fibrosis, which causes the lungs to be unable to properly move oxygen into the bloodstream. Idiopathic pulmonary fibrosis (IPF) refers...

Read more

To category page

Loading...